Outlook Therapeutics, Inc. (OTLK) NASDAQ
0.83
-0.0153(-1.81%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.83
-0.0153(-1.81%)
Currency In USD
| Market Cap | 36.88M |
| Enterprise Value | 59M |
| P/E Ratio | -1.11 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 102.21 |
| Price/Book Ratio | -2.34 |
| Enterprise/Revenue | 160.57 |
| Enterprise/EBITDA | -0.86 |
| Fiscal Year | September 30, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | -182.98 |
| Operating Margin | -181.83 |
| Return On Assets | -2.78 |
| Return On Equity | 1.78 |
| Revenue | 1.41M |
| Revenue/Share | 0 |
| Gross Profit | 657,205 |
| EBITDA | -63.58M |
| Net Income | -62.42M |
| Diluted EPS | -1.79 |
| Total Cash | 7.75M |
| Total Cash/Share | 0.09 |
| Total Debt | 27.19M |
| Total Debt/Equity | -0.94 |
| Current Ratio | 0.54 |
| Book Value Per Share | -0.35 |
| 52-Week Change | -53.24 |
| 52-Week High | 3.39 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.29 |
| Moving Average 200 Days | 0.95 |
| Average Volume | 13.9M |
| Shares Outstanding | 41.14M |
| % Held by Institutions | 17.82 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | March 14, 2024 |